4//SEC Filing
Ryll Thomas 4
Accession 0001179110-19-001233
CIK 0000855654other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:37 PM ET
Size
5.1 KB
Accession
0001179110-19-001233
Insider Transaction Report
Form 4
IMMUNOGEN INCIMGN
Ryll Thomas
VP, Technical Operations
Transactions
- Award
Stock Option (right to buy)
2019-01-31$5.25/sh+221,900$1,164,975→ 221,900 totalExercise: $5.25From: 2020-01-31Exp: 2029-01-31→ Common Stock (221,900 underlying)
Footnotes (1)
- [F1]Exercisable in three equal installments over the next three years starting on the first year anniversary of the grant.
Documents
Issuer
IMMUNOGEN INC
CIK 0000855654
Entity typeother
Related Parties
1- filerCIK 0001701531
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 4:37 PM ET
- Size
- 5.1 KB